These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6958113)

  • 1. Estradiol and progestin receptors, 17-beta-hydroxysteroid-dehydrogenase and histopathologic grade in endometrial carcinoma.
    Ciuffi M; Savino L; Santini D; Buzzoni P; Scarselli G; Mazzei T
    Tumori; 1982 Jun; 68(3):217-21. PubMed ID: 6958113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamentals and clinical significance of steroid hormone receptors, 17 beta-hydroxysteroid-dehydrogenase and serum tumor markers in endometrial carcinoma].
    Pollow K; Kreienberg R
    Gynakologe; 1983 Jun; 16(2):93-8. PubMed ID: 6576967
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17 beta-HSD activity in different age-groups and phases of the menstrual cycle.
    Eiletz J; Genz T; Pollow K; Schmidt-Gollwitzer M
    Arch Gynecol; 1980 Jan; 229(1):13-28. PubMed ID: 6244793
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
    Neumannova M; Kauppila A; Vihko R
    Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary.
    Vierikko P; Kauppila A; Vihko R
    Int J Cancer; 1983 Oct; 32(4):413-22. PubMed ID: 6311758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers].
    Fournier S; Allali F; Durand JC; Sterkers N; Debertrand P; Diebold N; Martin PM; Kuttenn F; Mauvais-Jarvis P
    Pathol Biol (Paris); 1985 Jun; 33(6):659-64. PubMed ID: 2995904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
    Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C
    Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma.
    Utsunomiya H; Suzuki T; Ito K; Moriya T; Konno R; Sato S; Yaegashi N; Okamura K; Sasano H
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):696-703. PubMed ID: 12780745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
    Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of the human 17 beta-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma.
    Mäentausta O; Boman K; Isomaa V; Stendahl U; Bäckström T; Vihko R
    Cancer; 1992 Sep; 70(6):1551-5. PubMed ID: 1325275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The level of steroid hormone receptors in endometrial cancer].
    Bieglmayer C; Spona J; Ulm R; Husslein P
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6211045
    [No Abstract]   [Full Text] [Related]  

  • 17. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
    Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma.
    Lantta M; Kahanpää K; Kärkkäinen J; Lehtovirta P; Wahlström T; Widholm O
    Gynecol Oncol; 1984 Jun; 18(2):233-9. PubMed ID: 6735266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
    Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
    Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.